NSCLC samples were processed to detect Th17 cells and Treg cells by flow cytometry, and the concentrations of IL-1β, IL-6, IL-10, IL-17, IL-23, and TGF-β1 were measured by enzyme-linked immunosorbent assay analysis. The gene discussed is IL17A; the disease is non-small cell lung carcinoma.